Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease

Authors

Karen E. Murphy, University of New South Wales
Amanda M. Gysbers, Neuroscience Research Australia
Sarah K. Abbott, University of WollongongFollow
Adena S. Spiro, University of Sydney, University of WollongongFollow
Akiko Furuta, National Center for Neurology & Psychiatry
Anthony Cooper, Garvan Institute Of Medical Research, University of New South Wales
Brett Garner, University of WollongongFollow
Tomohiro Kabuta, National Center for Neurology & Psychiatry
Glenda M. Halliday, University of Sydney

RIS ID

103996

Publication Details

Murphy, K. E., Gysbers, A. M., Abbott, S. K., Spiro, A. S., Furuta, A., Cooper, A., Garner, B., Kabuta, T. & Halliday, G. M. (2015). Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease. Movement Disorders, 30 (12), 1639-1647.

Abstract

Lysosomes are the primary catabolic compartment for the degradation of intracellular proteins through autophagy. The presence of abnormal intracellular -synuclein-positive aggregates in Parkinson's disease (PD) indicates that the degradative capacity of lysosomes is impaired in PD. Specific dysfunction of chaperone-mediated autophagy (CMA) in PD is suggested by reductions in the CMA membrane receptor, lysosomal-associated membrane protein (LAMP) 2A, although whether LAMP2A is the only LAMP2 isoform affected by PD is unknown. Messenger RNA (mRNA) and protein expression of all three LAMP2 isoforms was assessed in brain extracts from regions with and without PD-related increases in -synuclein in autopsy samples from subjects in the early pathological stage of PD (n=9), compared to age- and postmortem delay-matched controls (n=10). In the early stages of PD, mRNA expression of all LAMP2 isoforms was not different from controls, with LAMP2B and LAMP2C protein levels also unchanged in PD. The selective loss of LAMP2A protein directly correlated with the increased levels of -synuclein and decreased levels of the CMA chaperone heat shock cognate protein 70 in the same PD samples, as well as with the accumulation of cytosolic CMA substrate proteins. Our data show that LAMP2 protein isoforms are differentially affected in the early stages of PD, with LAMP2A selectively reduced in association with increased -synuclein, and suggests that dysregulation of CMA-mediated protein degradation occurs before substantial -synuclein aggregation in PD. (c) 2015 International Parkinson and Movement Disorder Society.

Grant Number

NHMRC/1008307